Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Bone-selective estrogen derivatives claimed by Sumitomo

March 25, 1997

Yakult Honsha discloses ACAT inhibitors

March 25, 1997

New drug therapy for erectile dysfunction more effective than PGE1

March 24, 1997

Lilly to discontinue or alter rHb1.1 collaboration with Somatogen

March 21, 1997

FDA clears Skelid

March 21, 1997

Amylin and J&J broaden collaboration

March 20, 1997

Collaboration formed to identify chronic anemia treatment

March 20, 1997

Phase II trial of Leukine as adjuvant for advanced melanoma

March 20, 1997

Grelan characterizes candidate for diabetic complications

March 20, 1997

Novel antihyperlipidemic agent from Shionogi in phase II

March 20, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...